衰老指标与慢性阻塞性肺病之间的关系,肺功能:NHANES的横截面研究,2007-2010年
Zhishen Ruan1, Dan Li1, Di Huang1
1Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
BMJ open
|November 2, 2023
概括
通过表型年龄加速 (PhenoAgeAccel) 测量加速的生物衰老与发展慢性阻塞性肺病 (COPD) 和肺功能减弱有关. 这突显了抗衰老疗法对COPD患者的潜在益处.
科学领域:
- 老年学和呼吸系统医学
- 衰老的生物标志物
- 肺部疾病研究研究
背景情况:
- 慢性阻塞性肺病 (COPD) 与衰老有很强的关联,但时间学年龄是对生物衰老的不足衡量标准.
- 现型年龄加速 (PhenoAgeAccel),即生物年龄和时间年龄之间的差异,为评估衰老提供了一个新的指标.
- 了解PhenoAgeAccel和COPD之间的联系对于开发有针对性的干预措施至关重要.
研究的目的:
- 为了调查PhenoAgeAccel和COPD的流行率之间的联系.
- 检查PhenoAgeAccel与肺功能客观测量的关系.
- 探索吸烟和呼吸道症状等因素如何与COPD的背景下与PhenoAgeAccel相关.
主要方法:
- 一项采用2007-2010年国家健康和营养检查调查 (NHANES) 数据的横截面研究.
- 40岁以上的参与者被归类为COPD,如果经过支气管扩张的FEV1/FVC<0.70.
- 线性和逻辑回归分析,包括子组分析和多种模型,用于评估PhenoAgeAccel对COPD和肺功能的影响.
主要成果:
- 更高的PhenoAgeAccel显着与COPD的可能性增加有关 (OR为Q4与Q1 = 1.52) 和肺功能降低.
- 升高的PhenoAgeAccel在COPD患者,老年人和白人参与者中对肺功能产生了更明显的影响.
- 呼吸系统症状和高吸烟指数与更高的PhenoAgeAccel相关,表明加快衰老.
结论:
- 根据PhenoAgeAccel的指标,加速的生物衰老是COPD发展和肺功能下降的重要因素.
- 这些发现表明,戒烟和抗衰老疗法可能具有治疗COPD的治疗潜力.
- PhenoAgeAccel 作为一个有价值的生物标志物,用于评估呼吸系统健康中与衰老相关的风险.
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.9K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.9K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K


